BLT 0.00% 2.6¢ benitec biopharma limited

From the company's website regarding Hepatitis C in-house...

  1. 2,524 Posts.
    lightbulb Created with Sketch. 69
    From the company's website regarding Hepatitis C in-house pipeline....

    "We believe that completing this work will provide us with valuable data that supports our ddRNAi technology platform and other pipeline programs."

    The only other data that they really haven't released is efficacy in the truest sense...some kind of viral load effect. Otherwise, what other data would they release that would be new?
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.